公开(公告)号：US11103545B2

公开(公告)日：2021-08-31

申请号：US14431179

申请日：2013-09-27

申请人： Shanta Banerjee

发明人： Shanta Banerjee

IPC分类号： A61K36/185 ,  A61K36/87 ,  A61K36/9066 ,  A61K36/48 ,  A61K36/47 ,  A61K45/06

摘要： The present invention relates to a composition a maximum of six, in particular a maximum of five or four different plant extracts for use in the prevention and/or treatment of diabetes type II or type 1. At least one plant extract has antioxidative properties and/or antioxidant enzyme inducing properties; at least one plant extract has anti-inflammatory properties; at least one plant extract has immune modulating properties; and at least one plant extract has neuronal hormone modulating properties.

公开(公告)号：US11083768B2

公开(公告)日：2021-08-10

申请号：US16824545

申请日：2020-03-19

申请人： Spirit Songs Botanicals

发明人： Manu Sai Malasquez

IPC分类号： A61K36/00 ,  A61K36/47 ,  A61K47/44 ,  A61K31/05

摘要： A cannabinoid composition comprising, purified water, hemp extract having a between 30-70% cannabidiol concentration. The hemp extract being a whole plant extract derived hemp. The composition includes 200-800 mg of ajo sacha paste dissolved in the water in a final concentration of 600 mg paste per 60 ml (2 oz) finished product. The composition further includes sangre de grado is added in the standardized aqueous commercial form at a concentration of 0.5 ml per 60 ml of finished product. The composition includes an excipient chosen from the group consisting of emulsifiers, preservatives, fragrance, flavorings, a carrier oil, and combinations thereof. A method of the invention includes adding these components together to form the composition. In particular, the method includes dissolving equal amounts of 30× Ajo Sacha paste in equal weight hot purified water. Providing a botanical carrier oil and mixing hep CBD oil, commercial Sangre de Grado solution, and Ajo Sacha solution to the botanical carrier oil.

公开(公告)号：US20210220419A1

公开(公告)日：2021-07-22

申请号：US17222768

申请日：2021-04-05

申请人： Moringo Organics Inc.

发明人： Karen Vieira ,  John Britto

IPC分类号： A61K36/31 ,  A61K36/9066 ,  A61K36/185 ,  A61K36/48 ,  A61K36/53 ,  A61K36/67 ,  A61K35/74 ,  A61K36/47 ,  A61P39/06 ,  A61P3/06 ,  A61P3/10 ,  A61K9/00 ,  A61K9/48 ,  A61K31/4525 ,  A61K35/04 ,  A61K35/748 ,  A61K36/61

摘要： The main objective of the present invention is to develop an herbal formulation with high polyphenol concentrations. A therapeutic effect of ingredients in herbal composition with Antioxidants, Anti-inflammatories, Anti Viral & Anti Microbial properties to reduce Oxidative Stress, Inflammation, Viral and Microbial Infections. The herbal composition promotes management of diabetes, regulation of cholesterol, also immune system processes that helps to fight against viral and bacterial infections, colds, or the flu, skin ailments such as Psoriasis & eczema. Herbal Composition comprises synergistic combination of Moringa oleifera Leaf Powder, Spirulina & Aqueous extracts of Oregano Vulgare Leaf Extract, Shilajit extract, Rosemary Leaf extract, Pomegranate Fruit Preel extract, Amla fruit extract, Fenugreek Seed Extract, Curcumin Extract, Piperine extract. Therefore, the chosen herbal blend provides the body with all of the vitamins, minerals, and nutrients it needs to continuously boost health.

公开(公告)号：US11045515B2

公开(公告)日：2021-06-29

申请号：US15791158

申请日：2017-10-23

申请人： ALLERGAN, INC.

发明人： Anuradha V. Gore ,  Robert S. Jordan ,  Kevin Krock ,  Chetan Pujara

IPC分类号： A61K36/55 ,  A61K9/00 ,  A61K9/107 ,  A61K47/44 ,  A61K36/47

摘要： The present invention provides ophthalmic compositions, e.g. artificial tears, suitable for treating dry eye syndrome in a human or other mammal suffering there from, e.g. a dog or cat, which comprise a mixture of castor oil with another oil, e.g. a food oil, e.g. olive oil, sesame oil, corn oil etc.

公开(公告)号：US20210128499A1

公开(公告)日：2021-05-06

申请号：US17140979

申请日：2021-01-04

申请人： Lee Heil Chae ,  Fred Levine

发明人： Lee Heil Chae ,  Fred Levine

IPC分类号： A61K31/165 ,  A61K36/8962 ,  A61K36/31 ,  A61K36/21 ,  A61K36/69 ,  A61K36/185 ,  A61K36/47 ,  A61K36/67 ,  A61K36/899 ,  A61K36/725 ,  A61K36/758 ,  A61K36/39 ,  A61K36/81 ,  A61K36/815 ,  A61P1/14 ,  A23L33/00 ,  A23L33/105

摘要： Disclosed herein are methods for improving digestive health by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.

公开(公告)号：US10967019B2

公开(公告)日：2021-04-06

申请号：US15715056

申请日：2017-09-25

申请人： TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO.,LTD.

发明人： Han-Chung Cheng ,  Chi-Tang Tu ,  Shun-Chieh Yang ,  Man-Ching Shen

IPC分类号： A61K36/185 ,  A61K9/00 ,  A61K9/08 ,  A61K36/47 ,  A61K9/48

摘要： A use of an emblica extract in preparing a pharmaceutical composition for protecting mitochondria in retina is provided. When the pharmaceutical composition, which comprises the emblica extract, is provided to retinal cells, a use of the pharmaceutical composition comprises improvement of the ability of performing the oxidative phosphorylation for the synthesis of the adenosine triphosphate (ATP) by the mitochondria in the retinal cells under or exposed to ultraviolet light, and improvement of the coupling efficiency of the synthesis of the adenosine triphosphate by the mitochondria.

公开(公告)号：US10953055B2

公开(公告)日：2021-03-23

申请号：US16297272

申请日：2019-03-08

申请人： Benny Antony

发明人： Benny Antony

IPC分类号： A61K36/00 ,  A61K36/185 ,  B01D11/02 ,  A61Q7/00 ,  A61K8/97 ,  A61K31/202 ,  A61K31/045 ,  A61K31/192 ,  A61K31/575 ,  A61K36/47 ,  A61K8/11 ,  A61K9/48 ,  A61K9/00 ,  A61K31/201

摘要： An extract of seeds of Emblica officinalis which has triterpenoids and hydroxycinnamic acids is provided. A blend of extracts of seeds of Emblica officinalis which includes an extract of seeds of Emblica officinalis having triterpenoids and hydroxycinnamic acids and an extract of seeds of Emblica officinalis having fatty acids, such as, alpha linolenic acid, linoleic acid and oleic acid is provided. Methods of preparing the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided. Methods of treatment administering the extracts of seeds of Emblica officinalis and methods of preparing the blend of extracts of seeds of Emblica officinalis are provided.

公开(公告)号：US20200376067A1

公开(公告)日：2020-12-03

申请号：US16754610

申请日：2018-10-18

申请人： YALE UNIVERSITY

发明人： Yung-Chi CHENG ,  WING LAM ,  ZAOLI JIANG

IPC分类号： A61K36/82 ,  A61K36/886 ,  A61K36/708 ,  A61K36/59 ,  A61K36/756 ,  A61K36/47 ,  A61K36/28 ,  A61K36/24 ,  A61K36/73 ,  A23L33/105

摘要： In one embodiment, the present invention is directed to a composition comprising an aqueous or ethanolic extract of at least one herb selected from the group consisting of Aloe barbadensis (:F3), Rheum palmatum L. (:B6), Stephania tetrandra (:C4), Phellodendron chinense Schneid. (:D8), Euphorbia humifusa (:S6), Eclipta prostrata (:I2), A. venetum L. (:F1), Portulaca oleracea L. (:F5), and Sanguisorba officinalis L. (:E5), Camellia sinensis var. assamica (Mast.) Kitamura (:PE) and Punica granatum. (:PG), and mixtures thereof. The composition is administered to a patient, in an effective amount, in a method of treating, inhibiting, preventing, reducing the incidence of, ameliorating or resolving a disease state or condition caused in part or exacerbated by hyperactivity of the androgen receptor (AR), by inhibiting the androgen receptor protein. These compositions may also be used inhibit or stabilize hair loss or grow hair in a subject in need.

公开(公告)号：US20200316154A1

公开(公告)日：2020-10-08

申请号：US16824545

申请日：2020-03-19

申请人： Spirit Songs Botanicals

发明人： Manu Sai Malasquez

IPC分类号： A61K36/47 ,  A61K31/05 ,  A61K47/44

摘要： A cannabinoid composition comprising, purified water, hemp extract having a between 30-70% cannabidiol concentration. The hemp extract being a whole plant extract derived hemp. The composition includes 200-800 mg of ajo sacha paste dissolved in the water in a final concentration of 600 mg paste per 60 ml (2 oz) finished product. The composition further includes sangre de grado is added in the standardized aqueous commercial form at a concentration of 0.5 ml per 60 ml of finished product. The composition includes an excipient chosen from the group consisting of emulsifiers, preservatives, fragrance, flavorings, a carrier oil, and combinations thereof. A method of the invention includes adding these components together to form the composition. In particular, the method includes dissolving equal amounts of 30× Ajo Sacha paste in equal weight hot purified water. Providing a botanical carrier oil and mixing hep CBD oil, commercial Sangre de Grado solution, and Ajo Sacha solution to the botanical carrier oil.

公开(公告)号：US10702544B2

公开(公告)日：2020-07-07

申请号：US16069496

申请日：2017-01-11

申请人： National University Corporation Tokyo Medical and Dental University

发明人： Emi Nishimura ,  Hiroyuki Matsumura

IPC分类号： A61K31/713 ,  A61K38/55 ,  A61K36/05 ,  A61K36/14 ,  A61K36/47 ,  A61K36/48 ,  A61K36/54 ,  A61K8/97 ,  A61K31/506 ,  A61K36/489 ,  A61K36/738 ,  A61K36/04 ,  A61K36/424 ,  A61Q5/00 ,  A61K48/00 ,  A61K31/7088 ,  C12Q1/37 ,  A61K36/30 ,  A61K36/74 ,  A61K36/23 ,  A61K36/60 ,  A61K36/185 ,  A61Q7/00 ,  A61K36/718 ,  A61K36/488 ,  A61K36/53 ,  A61K36/82 ,  A61K39/395 ,  A61K36/18 ,  A61K36/28 ,  A61K31/222 ,  A61K45/00 ,  A61P17/14 ,  A61K31/05 ,  A61K31/16 ,  A61K31/355 ,  A61K31/375 ,  A61K31/381 ,  A61K31/7048 ,  A61K31/13 ,  A61K36/00

摘要： The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.